by ODWAdmin | Jun 24, 2025
This study from researchers at MaineHealth utilized Next-Generation Metabolomics to identify a cardioprotective signature in mouse blood plasma, and activated mitochondrial activity and energy production in liver and brown adipose tissue.. Read the article now to find...
by ODWAdmin | Jan 23, 2025
Sex-Based Metabolomic Differences in Checkpoint Inhibitor Response This poster from our partners at TD2 (Translational Drug Development) highlights significant differences in tumor growth inhibition and treatment responses between obese and control diet-fed mice. Dive...
by ODWAdmin | Jan 22, 2025
Panome Bio Provides Advanced Microbiome Analysis with Next-Generation Metabolomics – Deepen Insights with Bile Acids, SCFAs, & More This application note provides a high level look at how Panome Bio’s Microbiome Function Analysis suite of services...
by ODWAdmin | Jan 17, 2025
Investigating systemic consequences following the depletion of native murine intestinal flora Panome Bio’s Microbiome Function Analysis was utilized to assess the systemic consequences of antibiotic-induced depletion of gut flora in mice. A three-armed approach...
by ODWAdmin | Jan 16, 2025
This sample data report utilizes a three-armed approach to provide the most comprehensive metabolomic profiling of microbiome function. With Next-Generation Metabolomics, a Bile Acid focused assay, and a Short Chain Fatty Acid focused assay, discover novel insights...
